Adverse Event Reporting System

Results: 638



#Item
561Nursing informatics / Centers for Disease Control and Prevention / International standards / Standards organizations / Health Level 7 / LOINC / Immunization registry / Vaccine Adverse Event Reporting System / Immunization / Health / Medicine / Medical informatics

Implementation Guide forImmunization Data Transactions using HL7 v2.3.1 (June 2006)

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2012-05-16 11:34:23
562Medicine / Drug safety / Public safety / Vaccination / Vaccines / Vaccine Adverse Event Reporting System / Vaccine Safety Datalink / Vaccine / Centers for Disease Control and Prevention / Prevention / Safety

External Peer Review of the Clinical Immunization Safety Assessment (CISA) Network

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2011-07-05 08:31:13
563Pharmaceutical sciences / Office of Criminal Investigations / Center for Drug Evaluation and Research / Federal Food /  Drug /  and Cosmetic Act / Online pharmacy / Adverse Event Reporting System / Food and Drug Administration / Health / Medicine

FDA Notifying Health Care Providers about the Risks of Purchasing Unapproved Injectable Cancer Medications from Unlicensed Sources

Add to Reading List

Source URL: www.fda.gov

Language: English
564Prevention / Drug safety / Centers for Disease Control and Prevention / Public safety / Virology / Vaccine Adverse Event Reporting System / Rotavirus vaccine / Vaccine Safety Datalink / Vaccine / Vaccines / Medicine / Vaccination

Ensuring the Safety of Vaccines in the United States

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2013-04-09 08:29:39
565Medicine / Pharmacology / Pharmaceutical industry / Clinical research / Federal Food /  Drug /  and Cosmetic Act / New Drug Application / Adverse Event Reporting System / Over-the-counter drug / Approved drug / Food and Drug Administration / Pharmaceuticals policy / Pharmaceutical sciences

Guidance for Industry Safety Labeling Changes — Implementation of Section 505(o)(4) of the FD&C Act

Add to Reading List

Source URL: www.fda.gov

Language: English
566Research / Adverse Event Reporting System / Structured Product Labeling / Center for Biologics Evaluation and Research / New Drug Application / Postmarketing surveillance / Federal Food /  Drug /  and Cosmetic Act / Food and Drug Administration / Medicine / Health

Guidance for Industry Providing Submissions in Electronic Format — Postmarketing Safety Reports DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

Add to Reading List

Source URL: www.fda.gov

Language: English
567Pharmaceutical sciences / Food and Drug Administration / Pharmaceuticals policy / Clinical research / Drug safety / Adverse Event Reporting System / Pharmacovigilance / Center for Biologics Evaluation and Research / Adverse event / Pharmacology / Medicine / Health

Guidance for Industry Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment

Add to Reading List

Source URL: www.fda.gov

Language: English
568Piperazines / Food and Drug Administration / Drug safety / Clinical research / Adverse Event Reporting System / Pharmacovigilance / Adverse effect / MedWatch / Valproic acid / Pharmacology / Medicine / Pharmaceutical sciences

EDIT _RIAL Pharmacovigilance in the 21st Century: New Systematic Tools for an Old Problem Ana Szarfman, M.D., Ph.D., Joseph M. Tonning, M.D., M.P.H., and P. Murali Doraiswamy, M.D. The large number of adverse-event repor

Add to Reading List

Source URL: www.fda.gov

Language: English
569Pharmaceutical sciences / Pharmacology / Unique Device Identification / Health informatics / Clinical research / Electronic health record / Adverse event / Adverse Event Reporting System / Medical device / Medicine / Health / Food and Drug Administration

STRENGTHENING OUR NATIONAL SYSTEM FOR MEDICAL DEVICE POSTMARKET SURVEILLANCE UPDATE AND NEXT STEPS

Add to Reading List

Source URL: www.fda.gov

Language: English
570Research / Adverse Event Reporting System / Center for Biologics Evaluation and Research / Validation / Regulatory requirement / New Drug Application / Biologic / Center for Drug Evaluation and Research / Postmarketing surveillance / Food and Drug Administration / Medicine / Pharmaceutical sciences

Guidance for Industry Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE